arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Nuo Therapeutics, Inc.

AURX

— Price unavailable

14 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Moderately Bearish

auto_awesome

Analytical Summary

Nuo Therapeutics, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap —

Dividend Yield —

Revenue Growth 142.7% ↗

Op. Margin -76.0% ↗

ROIC 263.1% ↗

FCF / Share $-0.02 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$3.31M

↑ +142.7% —

Net Income Profit after all expenses

$-2.51M

↓ -8.1% —

Operating Margin Operating profit as % of sales

-76.0%

↑ +57.8% 3th

FCF / Share Free cash flow per share

$-0.02

↑ +54.2% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

100

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗	FY 2012 Dec 31, 2009 10-K ↗
Revenue Growth YoY (%)	142.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1684%)	124.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1454%)	442.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5426%)	-23.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-390%)	—	N/M	-93.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1272%)	48.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+504%)	-32.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-512%)	9.5% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+19%)	45.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+472%)	85.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+966%)	—	—
EPS Growth YoY (%)	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	37.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	-60.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-8.1% Weak ↑ Weak Improving Year-over-year change in net income	26.7% Excellent ↑ Excellent Improving Year-over-year change in net income	0.0% Caution ↑ Caution Improving Year-over-year change in net income	-165.4% Weak ↑ Weak Improving Year-over-year change in net income	-1214.9% Weak ↓ Weak Declining Year-over-year change in net income	99.4% Excellent ↑ Excellent Improving Year-over-year change in net income	71.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-179.7% Weak ↓ Weak Declining Year-over-year change in net income	6.7% Fair ↑ Fair Improving Year-over-year change in net income	-2.3% Weak ↑ Weak Improving Year-over-year change in net income	-464.0% Weak Weak Year-over-year change in net income	48.5% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	54.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	30.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	19.9% Good ↑ Good Improving Year-over-year change in free cash flow	-142.3% Weak ↑ Weak Improving Year-over-year change in free cash flow	-1754.7% Weak Weak Year-over-year change in free cash flow	99.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	209.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	110.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	—	-46.2% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-76.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	—	-60.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	2.9% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	2.3% Caution Caution Compound annual revenue growth over 3 years	43.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	—	13.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-44.5% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-57.1% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-58.3% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	—	-37.0% Weak Weak Compound annual revenue growth over 5 years	24.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗	FY 2012 Dec 31, 2009 10-K ↗
Operating Margin (%) (%)	-76.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-606%)	-180.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1300%)	—	—	—	—	—	-359.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2493%)	-301.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2109%)	-156.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1143%)	-122.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-914%)	-48.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-423%)	-138.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1021%)	—
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
Profit Margin (%) (%)	-75.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-732%)	-170.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1518%)	—	—	—	—	—	-458.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3923%)	-243.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2127%)	-175.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1558%)	-187.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1662%)	-48.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-504%)	-174.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1552%)	—
FCF Margin (%) (%)	-34.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-174.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	-107.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-58.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-110.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.45x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.33x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.21x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗	FY 2012 Dec 31, 2009 10-K ↗
Return on Invested Capital (%)	263.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-478.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-304.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-151.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	80.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	461.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-2541.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	112.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-151.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-68.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-84.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	5385.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-136.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-206.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-168.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-109.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-350.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-1090.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-584.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-60.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	262.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1651%)	—	—	-144.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1065%)	98.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+559%)	110.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+639%)	—	144.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+863%)	-122.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-914%)	-77.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-613%)	-52.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-447%)	-107.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-813%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗	FY 2012 Dec 31, 2009 10-K ↗
Debt to Equity (x)	—	—	—	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-533.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-546.91x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-791.47x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1464.11x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.38x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.81x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1438.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.05x Weak Weak Operating income divided by interest expense Optimal: > 5x	-13.74x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—
Net Debt (USD)	$-548.95K	$-283.71K	$-928.68K	$-2.05M	$-20.25K	$0.00	$-693.51K	$-922.32K	$-15.95M	$-3.29M	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗	FY 2012 Dec 31, 2009 10-K ↗
Revenue per Share (USD)	$0.07	$0.03	$0.01	$0.00	$0.01	$0.00	$0.05	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.05	$-0.05	$-0.08	$-0.08	$-0.05	$0.30	$-1.02	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.02	$-0.05	$-0.08	$-0.09	$-0.04	$-0.00	$-0.33	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.02	$0.01	$0.02	$0.05	$-0.05	$-0.00	$0.02	$-0.29	$0.12	$0.25	$0.41	$0.06	$-0.00	—
Tangible Book Value per Share (USD)	$-0.02	$0.01	$0.02	$0.05	$-0.05	$-0.00	$0.02	$-0.31	$-0.11	$-0.08	$0.03	$-0.01	$-0.09	—
Basic Weighted Avg Shares (shares)	47.31M	45.42M	42.08M	40.00M	23.72M	25.69M	14.65M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗	FY 2012 Dec 31, 2009 10-K ↗
Working Capital (USD)	$73.60K	$263.10K	$888.92K	$2.03M	$-1.21M	$-1.03M	$248.27K	$-39.14M	$12.90M	$-606.67K	$3.63M	$2.02M	$-1.68M	—
LT Debt (USD)	—	—	—	—	$0.00	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$-956.56K	$513.71K	$1.04M	$2.19M	$-1.21M	$-81.99K	$482.87K	$-36.56M	$15.47M	$26.31M	$38.00M	$3.28M	$-79.25K	$976.05K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗	FY 2012 Dec 31, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	$3.31M	$1.37M	$608.52K	$112.25K	$146.18K	$0.00	$721.04K	$11.51M	$7.76M	$11.57M	$10.56M	$7.25M	$3.91M	—
Depreciation Expense (USD)	$85.46K	$23.02K	$15.33K	$6.83K	$89.86K	$0.00	$1.11M	$740.97K	$613.50K	$1.09M	$1.18M	$631.18K	$440.18K	—
Net Income, GAAP (USD)	$-2.51M	$-2.32M	$-3.17M	$-3.17M	$-1.19M	$-90.87K	$-14.98M	$-52.81M	$-18.88M	$-20.25M	$-19.80M	$-3.51M	$-6.82M	—
Operating Cash Flow (USD)	$-864.97K	$-2.23M	$-3.17M	$-3.71M	$-921.67K	$-53.82K	$-4.90M	—	—	—	$-11.39M	$-4.24M	$-3.54M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 54 quarters

Nuo Therapeutics, Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AURX with peers